{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:25:10Z","timestamp":1790785510406,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.eururo.2016.10.046","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T12:45:37Z","timestamp":1479473137000},"page":"926-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["[ 18 F]-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis, Treatment Stratification, and Monitoring of Patients with Retroperitoneal Fibrosis: A Prospective Clinical Study"],"prefix":"10.1016","volume":"71","author":[{"given":"Archie","family":"Fernando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Pattison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Horsfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"D\u2019Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2016.10.046_bib0150","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10067-015-3022-y","article-title":"Idiopathic retroperitoneal fibrosis: clinicopathologic features and outcome analysis","volume":"35","author":"Yachoui","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.eururo.2016.10.046_bib0155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bju.13061","article-title":"A lot of questions (and a few answers \u2026) in retroperitoneal fibrosis","volume":"117","author":"Fernando","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.10.046_bib0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","article-title":"Retroperitoneal fibrosis","volume":"367","author":"Vaglio","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2016.10.046_bib0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/1756287214565637","article-title":"Management of idiopathic retroperitoneal fibrosis from the urologist's perspective","volume":"7","author":"Surce","year":"2015","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.eururo.2016.10.046_bib0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4065\/mcp.2010.0663","article-title":"Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes","volume":"86","author":"Kermani","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.eururo.2016.10.046_bib0175","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MD.0b013e3181afc4d1","article-title":"Retroperitoneal fibrosis: new insights into clinical presentation and diagnosis","volume":"88","author":"Vaglio","year":"2009","journal-title":"Medicine"},{"key":"10.1016\/j.eururo.2016.10.046_bib0180","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10067-010-1580-6","article-title":"Idiopathic retroperitoneal fibrosis (RPF): clinical features of 61 cases and literature review","volume":"30","author":"Li","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.eururo.2016.10.046_bib0185","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MD.0b013e3181afc439","article-title":"Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation","volume":"88","author":"Scheel","year":"2009","journal-title":"Medicine"},{"key":"10.1016\/j.eururo.2016.10.046_bib0190","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.semnuclmed.2008.10.006","article-title":"Functional imaging of inflammatory diseases using nuclear medicine techniques","volume":"39","author":"Basu","year":"2009","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.eururo.2016.10.046_bib0195","first-page":"175","article-title":"The Use of F-FDG-PET\/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases","volume":"42","author":"Glaudemans","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.eururo.2016.10.046_bib0200","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ejrad.2010.01.021","article-title":"Role of FDG-PET and PET\/CT in the diagnosis and management of vasculitis","volume":"73","author":"Zerizer","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.eururo.2016.10.046_bib0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1749-6632.2011.06031.x","article-title":"FDG PET for rheumatoid arthritis: basic considerations and whole-body PET\/CT","volume":"1228","author":"Kubota","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.eururo.2016.10.046_bib0210","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jacc.2007.05.024","article-title":"18-Fluorodeoxygucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible","volume":"50","author":"Rudd","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.eururo.2016.10.046_bib0215","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3390\/cancers6041821","article-title":"Positron emission tomography (PET) in oncology","volume":"6","author":"Gallamini","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.eururo.2016.10.046_bib0220","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1148\/rg.232025705","article-title":"Clinical role of FDG PET in evaluation of cancer patients","volume":"23","author":"Kostakoglu","year":"2003","journal-title":"Radiographics"},{"key":"10.1016\/j.eururo.2016.10.046_bib0225","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2016.10.046_bib0230","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.eururo.2012.11.056","article-title":"Immunoglobulin G4-related disease in genitourinary organs: an emerging fibroinflammatory entity often misdiagnosed preoperatively as cancer","volume":"64","author":"Montironi","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.10.046_bib0235","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/00365599409181272","article-title":"Retroperitoneal fibrosis treated with methylprednisolone pulse and disease-modifying antirheumatic drugs","volume":"28","author":"Harreby","year":"1994","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.eururo.2016.10.046_bib0240","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0272-6386(99)70414-2","article-title":"Incidence and long-term cost of steroid-related side effects","volume":"33","author":"Veenstra","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.eururo.2016.10.046_bib0245","first-page":"231","article-title":"Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent \u201cscar\u201d? A study using 18F-fluorodeoxyglucose positron emission tomography","volume":"23","author":"Vaglio","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.eururo.2016.10.046_bib0250","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.rct.0000284388.45579.05","article-title":"18F-Fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis","volume":"31","author":"Nakajo","year":"2007","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.eururo.2016.10.046_bib0255","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12149-007-0077-0","article-title":"Hypermetabolic activity in patients with active retroperitoneal fibrosis on F-18 FDG PET: report of three cases","volume":"22","author":"Young","year":"2008","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.eururo.2016.10.046_bib0260","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejim.2010.02.008","article-title":"18F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis","volume":"21","author":"Jansen","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.eururo.2016.10.046_bib0265","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1093\/ndt\/gfq051","article-title":"Positron emission tomography as a tool for the \u2018tailored\u2019 management of retroperitoneal fibrosis: a nephro-urological experience","volume":"25","author":"Piccoli","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.eururo.2016.10.046_bib0270","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00296-012-2576-0","article-title":"Emerging role of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review","volume":"33","author":"Treglia","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.eururo.2016.10.046_bib0275","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11604-012-0066-7","article-title":"[18F]-FDG-PET\/CT in patients affected by retroperitoneal fibrosis: a bicentric experience","volume":"30","author":"Bertagna","year":"2012","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.eururo.2016.10.046_bib0280","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/RLU.0b013e3182478bd3","article-title":"18F-FDG PET\/CT and contrast-enhanced CT in a one-stop diagnostic procedure: a better strategy for management of patients suffering from retroperitoneal fibrosis?","volume":"37","author":"Guignard","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.eururo.2016.10.046_bib0285","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.revmed.2013.02.002","article-title":"Fibrose(s) retroperitoneale(s): strategie diagnostique, pathologies associees et suivi a long term d\u2019une cohort Francaise","volume":"34","author":"Lugosi","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.eururo.2016.10.046_bib0290","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4103\/0366-6999.152648","article-title":"Retroperitoneal fibrosis: a retrospective clinical data analysis of 30 patients in a 10-year period","volume":"128","author":"Zhou","year":"2015","journal-title":"Chin Med J (Engl)"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283816307606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283816307606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T15:19:24Z","timestamp":1568560764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283816307606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0302283816307606"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2016.10.046","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[18F]-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis, Treatment Stratification, and Monitoring of Patients with Retroperitoneal Fibrosis: A Prospective Clinical Study","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2016.10.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}